Position statement for the need to define pediatric hematology/oncology programs: A model of subspecialty care for chronic childhood diseases

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 2, 1998, Pages 98-103

  Arceci, Robert J ^a   Reaman, Gregory H ^c   Cohen, Alan R ^b   Lampkin, Beatrice C ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DISEASE; CHILDHOOD CANCER; CHILDHOOD DISEASE; CHRONIC DISEASE; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; CHILD; HEMATOLOGIC NEOPLASMS; HUMANS; PATIENT CARE TEAM;

EID: 0031924941     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199803000-00002     Document Type: Review

References (36)

1. Miller BA, Ries LAG, Hankey BF, et al. Cancer Statistics Review 1973-1989. National Cancer Institute. NIH Publication No. 92-2789, 1992.
2. Bleyer WA. What can be learned about childhood cancer from "Cancer Statistics Review 1973-1988." Cancer 1993;71:3229-36.
3. Lukens J. Progress resulting from clinical trials: solid tumors in childhood cancer. Cancer 1994;74:2710-8.
4. Progress against childhood cancer: The Pediatric Oncology Group experience. Pediatrics 1992;89:597-600.
5. American Academy of Pediatrics, Oncology-Hematology Section. Guidelines for pediatric cancer centers and role for such centers in diagnosis and treatment. Pediatrics 1986;77:916-7.
6. American Academy of Pediatrics Section on Oncology-Hematology. Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement Section on Hematology/Oncology. Pediatrics 1997;99:139-41.
7. Murphy SB. The national impact of clinical cooperative group trials for pediatric cancer. Med Pediatr Oncol 1995;24:279-80.
8. Ross JA, Severson RK, Robinson LL, et al. Pediatric cancer in the United States: a preliminary report of a collaborative study of the Children's Cancer Group and the Pediatric Oncology Group. Cancer 1993;71:3415-21.
9. Meadows AT, Kramer S, Lustbader E, et al. Survival in childhood acute lymphocytic leukemia: effect of protocol and place of treatment. Cancer Invest 1983;1:149-55.
10. Lange B, Woods W, Lampkin B, et al. Children's Cancer Group trials for acute myeloid leukemia in children: a cross study analysis of CCG-251, CCG 213 and CCG 286. In: Buchner T, Hiddenn W, Wormann B, et al. Acute Leukemia 4th ed. New York: Springer Verlag, 1994:724-31.
11. Wagner HP, Dingeldein-Bettler I, Berchthold W, et al. Childhood NHL in Switzerland: Incidence and survival of 120 study and 42 non-study patients. Med Pediatr Oncol 1995;24:281-6.
12. Stiller CA. Centralization of treatment and survival rates for cancer. Arch Dis Child 1988;63:23-30.
13. Kramer S, Meadows AT, Pastore G, et al. Influence of place of treatment on diagnosis, treatment and survival in three pediatric solid tumors. J Clin Oncol 1984;2:917-23.
14. Duffner PK, Cohen ME, Flannery JT. Referral patterns of childhood brain tumors in the state of Connecticut. Cancer 1982;50:1636-40.
15. Burgert EO, Nesbit ME, Garnesey LA, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990;8:1514-24.
16. Nesbit ME, Gehan EA, Burgert EO, et al. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of the bone: a long term follow-up of the first intergroup study. J Clin Oncol 1990;8:1664-74.
17. Link MP, Goorin AM, Miser AW, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-6.
18. Winkler K, Beron G, Delling U, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS = 82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988;6:329-37.
19. Lennox EL, Stiller CA, Morris-Jones PH, et al. Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J 1979;2:567-9.
20. Nachman J, Sather HN, Buckley JD, et al. Young adults 16-21 years of age at diagnosis entered on Children's Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment. Cancer 1993;15:3377-85.
21. Hammond GD, Nixon DW, Nachman JB, et al. American Cancer Society workshop on adolescents and young adults with cancer. Workgroup 4: Clinical research implications. Cancer 1993;71:2423.
22. Reaman GH, Bonfiglio J, Krailo M, et al. Cancer in adolescents and young adults. Cancer 1993;15:3206-9.
23. Link MP, Donaldson SS, Berard CW, et al. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 1990;322:1169-74.
24. Pritchard J, Stiller CA, Lennox EL. Overtreatment of children with Wilms' tumor outside pediatric oncology centers. Br J Med 1989;299:835-6.
25. Smith PS, Keyes NC, Forman EN. Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program. N Engl J Med 1982;306:575-9.
26. Levine PH, McVerry BA, Segelman AE, et al. Comprehensive health care clinic for hemophiliacs. Arch Intern Med 1976;136:792-4.
27. Association of Hemophilia Clinic Directors of Canada. Hemophilia and vonWillebrand's disease: 2. Management. Can Med Assoc J 1995;153:147-57.
28. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease: The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995; 333:206-13.
29. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. N Engl J Med 1986;314:1593-9.
30. NIH Office of Medical Applications of Research. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 1987;258:1205-9.
31. Leikin SL, Gallagher D, Kinney TR, et al. Mortality in children and adolescents with sickle cell disease. Pediatrics 1989;84:500-8.
32. Charache S, Terrin ML, Moore RD, et al. Effects of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22.
33. Yang YM, Shah AK, Watson M, et al. Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep 1995;110:80-6.
34. Jenney ME, Kane RL, Lurie N. Developing a measure of health outcomes in survivors of childhood cancer: a review of the issues. Med Pediatr Oncol 1995;24:145-53.
35. Noll RB, Panoletko T, Sulzbacker S. Psychosocial support. In: Ablin AR (ed). Supportive Care of Children with Cancer: Current Therapy and Guidelines from the Children's Cancer Group. Baltimore: Johns Hopkins, 1993:151-63.
36. Kisker CT, Strayer F, Wong K, et al. Health outcomes of a community based therapy program for children with cancer- a shared-management approach. Pediatrics 1980;66:900-6.